Detailed descriptions of the Mediterranean diet were poorly reported in the included studies, and thus this limited us to do further analysis to evaluate the effects of Mediterranean diet on cognitive disorders.
Nine elements of quality reporting were well reported; however, 2 others were poorly reported; this may improve if editors of pediatric surgical journals provide authors with guidelines on how to report clinical trial design and analysis.
More than 66% of all RCT in JPS reported on eligibility criteria, admission before allocation, random allocation, method of randomization, patients' blindness to treatment, treatment complications, statistical analyses, statistical methods, loss to follow-up, and statistical methods; 2 elements of design and analysis, however, were poorly reported: blind assessment of outcome (33%) and power (17%).
Global assessment and quality of life measures were poorly reported.
Two trials were poorly reported, limiting accurate assessment of their internal validity [55,56].
The final yields of nanoparticle product were poorly reported, and similar yields as for the arc process were assumed.
Other forms of CAM, particularly the energy medicine and mind body medicine forms were poorly reported.
Two other STARD items were poorly reported (less than 50% of time): participant sampling method (31%) and statistical methods to calculate diagnostic accuracy and uncertainty/precision (47%).
They are powerful tools, as has been proved by the fact that the majority of their items were well reported, with a few exceptions (7 CONSORT items and 9 STRICTA ones were poorly reported).
Overall, context factors were poorly reported.
These were poorly reported in most studies.
